髋关节表面置换翻修术后的结果如何
本研究回顾了本中心42例(43髋)髋关节表面置换术后翻修患者,翻修至多种假体(4髋再次表面置换,39髋全髋关节置换)。翻修后平均随访8.3年,疼痛与功能评分与初次表面置换后最佳水平相当,活动评分较低,SF-12心理评分下降;以再翻修为终点,13年Kaplan-Meier生存率为85.3%。作者认为翻修后可获得与初次术后最佳状态相似的功能与生活质量,再翻修风险低。
要点
- 翻修后平均随访8.3年,UCLA疼痛与功能评分与初次表面置换后最佳评分相当。
- 翻修后UCLA活动评分低于初次术后,SF-12心理评分下降而躯体评分相当。
- 以再翻修为终点,13年Kaplan-Meier生存率为85.3%。
核心结论
- 髋关节表面置换翻修患者可获得与初次手术后最佳状态相似的功能与生活质量,再翻修风险低。
研究设计与样本
- 回顾性分析本中心42例患者(43髋)髋关节表面置换翻修术后资料,翻修假体包括4髋再次表面置换和39髋全髋关节置换。
- 收集围手术期并发症、加州大学洛杉矶分校(UCLA)髋关节评分及12项简表健康调查问卷(SF-12)生活质量评分,随访时间点为初次表面置换后及翻修术后。
主要发现
- 翻修术后平均随访8.3年(范围0.3至19.1年)。
- 翻修后UCLA疼痛与功能评分与患者初次表面置换后达到的最佳评分相当,但翻修后UCLA活动评分较低。
- SF-12躯体成分评分在两个时间点相当,心理成分评分在翻修后下降。
- 6例患者在平均随访7.8年(范围0.3至13.7年)时接受单侧再翻修手术。
- 以任何再翻修时间为终点,13年Kaplan-Meier生存率为85.3%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Hip resurfacing arthroplasty (HRA) is typically indicated for young and active patients. Due to the longevity of arthroplasty, these patients are likely to undergo revision surgery during their lifetime. There is a paucity of information on the long-term outcome of revision surgeries performed after failed HRA. The aim of our study was to provide survivorship data as well as clinical scores after HRA revisions. METHODS: A total of 42 patients (43 hips) were revised after HRA at our centre to a variety of devices, including four HRA and 39 total hip arthroplasties (THAs). In addition to perioperative complications, University of California, Los Angeles (UCLA) hip scores and 12-Item Short-Form Health Survey questionnaire (SF-12) quality of life scores were collected at follow-up visits after the primary HRA and after revision surgery. RESULTS: The mean follow-up time after revision surgery was 8.3 years (0.3 to 19.1). The mean UCLA pain and function scores post-revision were comparable with the best scores achieved by the patients after the index HRA, but UCLA activity scores were lower after revision. SF-12 physical component scores were comparable between timepoints, but the mental component score decreased after revision. Six patients underwent unilateral re-revision surgery at a mean follow-up time of 7.8 years (0.3 to 13.7). Using the time to any re-revision as endpoint, the Kaplan-Meier survivorship was 85.3% at 13 years. CONCLUSION: Patients undergoing revision after HRA can expect to achieve function and quality of life similar to their best after their primary surgery, while the risk of re-revision is low. Cite this article: Bone Joint J 2020;102-B(10):1289-1296.
引用
- Amstutz HC, Le Duff M. What are the results of revised hip resurfacing arthroplasties? Bone Joint J. 2020. PMID: 32993340. doi:10.1302/0301-620X.102B10.BJJ-2020-0147.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。